Molecular Partners Ag (MOLN) EBIT (2021 - 2025)
Historic EBIT for Molecular Partners Ag (MOLN) over the last 5 years, with Q3 2025 value amounting to -$15.1 billion.
- Molecular Partners Ag's EBIT fell 8941961746.93% to -$15.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.1 billion, marking a year-over-year decrease of 8520470.29%. This contributed to the annual value of -$69.57 for FY2024, which is 20099.41% down from last year.
- As of Q3 2025, Molecular Partners Ag's EBIT stood at -$15.1 billion, which was down 8941961746.93% from -$20.92 recorded in Q2 2025.
- Molecular Partners Ag's EBIT's 5-year high stood at $165.2 billion during Q1 2022, with a 5-year trough of -$20.5 billion in Q1 2021.
- Over the past 5 years, Molecular Partners Ag's median EBIT value was -$16312.6 (recorded in 2023), while the average stood at $9.9 billion.
- In the last 5 years, Molecular Partners Ag's EBIT surged by 90597.5% in 2022 and then tumbled by 8941961746.93% in 2025.
- Quarter analysis of 5 years shows Molecular Partners Ag's EBIT stood at $51.7 billion in 2021, then plummeted by 99.77% to $120.9 million in 2022, then crashed by 99.96% to $50191.1 in 2023, then rose by 5.44% to $52923.0 in 2024, then tumbled by 28451138.84% to -$15.1 billion in 2025.
- Its EBIT stands at -$15.1 billion for Q3 2025, versus -$20.92 for Q2 2025 and -$17953.9 for Q1 2025.